- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04453956
A Single Center Study on Comparing the Different Function of EndoAngel in Improving the Quality of Colonscopy
October 19, 2020 updated by: Renmin Hospital of Wuhan University
A Prospective, Randomized, Single-blind, 2 × 2 Factorial Design Single Center Study Evaluating the Polyp Detection and Quality Monitoring Function of EndoAngel in Improving the Quality of Colonoscopy
An artificial intelligence-based system, named EndoAngel,has been constructed previously,which has polyp detection and quality monitoring functions.
This study aims to evaluate the two different functions of EndoAngle in improving adenoma detection rate.
Study Overview
Status
Unknown
Conditions
Detailed Description
The detection and removal of precancerous polyps via colonoscopy can reduce the the risk of colon cancer.
However, the detection rate of adenomatous polyps can vary significantly among endoscopists.
EndoAngel is an artificial intelligence-based system,consisting of polyp detection and quality monitoring functions.
The polyp detection function can remind endoscopists of the location of the polyp.
The quality monitoring function can monitor the velocity of insertion of the endoscope, record the time of insertion and withdrawal of the endoscope, and remind endoscopists of the blind areas caused by intestinal segment slipping.This study aims to evaluate the two different functions of EndoAngle by 2 × 2 factorial design in improving adenoma detection rate and the quality of colonscopy .
Study Type
Interventional
Enrollment (Anticipated)
1090
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430060
- Recruiting
- Renmin Hospital of Wuhan University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female aged 18 years or above;
- Colonoscopy is needed to further characterize gastrointestinal diseases;
- Ability to read, understand and sign informed consent forms;
- The researchers believe that the subjects can understand the process of the clinical study and are willing and able to complete all the study procedures and follow-up visits to cooperate with the study procedures.
Exclusion Criteria:
- Participated in other clinical trials, signed informed consent forms and followed up in other clinical trials;
- Participate in a drug clinical trial and during the elution period of the trial or control drug;
- Drug or alcohol abuse or mental disorder in the last 5 years;
- Pregnant or lactating women;
- Patients with multiple polyp syndrome;
- Patients with a history of inflammatory bowel disease, colorectal cancer, or colorectal surgery;
- Patients with known perforation or colonic obstruction;
- Patients with a contraindication for biopsy;
- The researchers did not consider the subjects suitable for colonoscopy;
- The researchers determined that the subjects had high-risk diseases or other special conditions that were not appropriate for clinical trials.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Control group
Patients will receive colonoscopy without assistance of EndoAngel's any function.
|
Patient in this group will receive colonoscopy with assistance of EndoAngel's both functions.
|
|
Experimental: Polyp detection function group
Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection function.
|
Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.
|
|
Experimental: Quality monitoring function group
Patients will receive colonoscopy with the assistance of EndoAngel's quality monitoring function.
|
Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.
|
|
Experimental: Polyp detection plus quality monitoring functions group
Patients will receive colonoscopy with the assistance of EndoAngel's polyp detection plus quality monitoring function.
|
Patient in this group will receive colonoscopy with assistance of EndoAngel's polyp detection function,which can remind endoscopists of the location of the polyp.
Patient in this group will receive colonoscopy with assistance of EndoAngel's quality monitoring function,which can monitor the withdrawal speed of the endoscope.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adenoma detection rate
Time Frame: 3 Months
|
The numerator is the number of cases of adenomas detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.
|
3 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Polyp detection rate
Time Frame: 3 months
|
The numerator is the number of cases of polyps detected by colonoscopy, and the denominator is the total number of cases of patients undergoing colonoscopy.
|
3 months
|
|
The mean number of polyps per procedure
Time Frame: 3 months
|
The numerator is the total number of polyps detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
|
3 months
|
|
The mean number of adenomas per procedure
Time Frame: 3 months
|
The numerator is the total number of adenomas detected by colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
|
3 months
|
|
Detection rate of large, small and diminutive polyps
Time Frame: 3 months
|
The numerator was the number of patients with large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
|
3 months
|
|
The mean number of large, small and diminutive polyps per procedure
Time Frame: 3 months
|
The numerator was the number of large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) polyps detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
|
3 months
|
|
Detection rate of large, small and diminutive adenomas
Time Frame: 3 months
|
The numerator was the number of patients with large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
|
3 months
|
|
The mean number of large, small and diminutive adenomas per procedure
Time Frame: 3 months
|
The numerator was the number of large (≥10 mm), small (>5 to <10 mm), and diminutive(≤5 mm) adenomas detected by colonoscopy, and the denominator was the total number of patients receiving colonoscopy.
|
3 months
|
|
Detection rate of adenoma in different sites
Time Frame: 3 months
|
The numerator is the number of cases of adenoma detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
|
3 months
|
|
The mean number of adenomas in different sites per procedure
Time Frame: 3 months
|
The numerator is the total number of adenomas detected in the rectum, sigmoid colon, descending colon, transverse colon, ascending colon and ileocecal region during colonoscopy, and the denominator is the total number of patients undergoing colonoscopy.
|
3 months
|
|
Time of colonoscopic insertion
Time Frame: 3 months
|
The duration of colonoscopic insertion from rectum to ileocecal valve or appendiceal opening
|
3 months
|
|
Time of colonoscopic withdrawal
Time Frame: 3 months
|
The duration of colonoscopic withdrawal from ileocecal valve or appendiceal opening to colonoscopy finished.
|
3 months
|
|
Cecal intubation rate
Time Frame: 3 months
|
The numerator is the number of cases of colonoscopy reaching ileocecal valve or appendiceal opening, and the denominator is the total number of colonoscopy cases.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2020
Primary Completion (Anticipated)
October 20, 2020
Study Completion (Anticipated)
October 30, 2020
Study Registration Dates
First Submitted
June 27, 2020
First Submitted That Met QC Criteria
June 27, 2020
First Posted (Actual)
July 1, 2020
Study Record Updates
Last Update Posted (Actual)
October 22, 2020
Last Update Submitted That Met QC Criteria
October 19, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EA-19-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adenoma
-
Robert Bosch Gesellschaft für Medizinische Forschung...Ovesco Endoscopy AG; Tuebingen Scientific Medical GmbHRecruitingAdenoma Colon | Adenoma Colon PolypGermany
-
London North West Healthcare NHS TrustCompletedAdenoma Colon | Serrated AdenomaUnited Kingdom
-
Mansoura UniversityWithdrawn
-
Fondazione Poliambulanza Istituto OspedalieroCompletedAdenoma Colon | Colonic AdenomaItaly
-
Alexandra Hospital, Athens, GreeceCompletedColonoscopy | Adenoma Detection Rate | Adenoma Miss Rate | RetroflexionGreece
-
Hospital Sirio-LibanesCompletedColorectal Cancer | Colonoscopy | Adenoma Detection Rate | Adenoma Colon | Colorectal Polyp | Sessile Serrated Adenoma | Quality IndicatorBrazil
-
University Hospital, BordeauxRecruitingMild Autonomous Cortisol Secretion Adenoma | Non Secreting AdenomaFrance
-
Seoul National University HospitalNot yet recruitingSessile Serrated Adenoma | Adenoma Colon Polyp
-
WAYCEN IncActive, not recruitingCarcinoma | Adenoma | Colorectal Adenoma | Hyperplastic Polyp | Sessile Serrated Lesion | Non-AdenomaSouth Korea
-
Azienda Unità Sanitaria Locale della RomagnaRecruitingAmpulla of Vater Adenoma | Ampullary Cancer | Ampulla of Vater Cancer | Ampullary AdenomaItaly
Clinical Trials on Colonoscopy without the assistance of EndoAngel's any function.
-
Ruijin HospitalPeking University Cancer Hospital & Institute; Wuhan Central HospitalCompleted
-
Renmin Hospital of Wuhan UniversityUnknown
-
Renmin Hospital of Wuhan UniversityUnknownAdenoma Detection RateChina
-
Istituto Clinico HumanitasRecruiting
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingUrolithiasis | AntibioticsChina
-
Centre hospitalier de l'Université de Montréal...University Hospital, BrestCompleted
-
EgymedicalpediaCompleted
-
Bandırma Onyedi Eylül UniversityCompletedNon-Alcoholic Fatty Liver DiseaseTurkey
-
University Hospital, BrestCompletedHypoxemic Acute Respiratory Distress | Infant Between 1 Month and 24 Months Old | Child Between 2 and 15 Years OldFrance
-
University of PalermoCompleted